Cleave Biosciences, Inc. is a biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer. Their innovative approach targets specific pathways within cancer cells to inhibit their growth and spread. Through cutting-edge research and strategic partnerships, Cleave Biosciences is committed to advancing the field of oncology and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#33 in Burlingame, CA

#9,511 in California

#39,950 in US

Burlingame, CA, United States of America

Cleave Biosciences, Inc.

Forward Citations = 9

10 inventors:

Han-Jie Zhou (7 out of 37 patents)

David Juergen Wustrow (6 out of 29 patents)

Francesco Parlati (3 out of 21 patents)

4. Jeffrey Aube (1 out of 21 patents)

5. Kevin Frankowski (1 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cleave Biosciences, Inc.. Retrieved from https://idiyas.com/company/cleave-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]